| 1 day | +2.45% |
| Manager | Title | Age | Since |
|---|---|---|---|
Carl Merton
CEO | Chief Executive Officer | 57 | 2023-06-21 |
Pamela McRae
CTO | Chief Tech/Sci/R&D Officer | - | - |
Richard Redekop
COO | Chief Operating Officer | - | 2022-06-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Vincent Chiara
BRD | Director/Board Member | - | 2016-11-03 |
Peter Montour
BRD | Director/Board Member | - | 2021-08-29 |
William Montour
BRD | Director/Board Member | - | 2022-01-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.45% | -7.31% | - | - | 29.39M | ||
| +3.89% | +0.71% | +310.43% | +18.89% | 2.64B | ||
| +5.52% | -10.99% | +147.66% | +127.02% | 1.73B | ||
| +0.43% | -9.89% | -15.95% | +113.94% | 459M | ||
| 0.00% | +6.67% | +26.32% | -20.00% | 51.65M | ||
| Average | +2.46% | -3.08% | +117.11% | +59.96% | 1.22B | |
| Weighted average by Cap. | +4.09% | -3.53% | +218.98% | +65.77% |
Employees
-
Sector
Pharmaceuticals
















